Literature DB >> 8287983

Limbal transplantation in the management of chronic contact-lens-associated epitheliopathy.

C Jenkins1, S Tuft, C Liu, R Buckley.   

Abstract

We describe the clinical management of 6 patients who developed a chronic corneal epitheliopathy 1-18 years after commencing soft contact lens wear. All had a history of exposure to thiomersal in contact lens fluids. The corneal changes were characterised by epithelial haze and superficial stromal vascularisation which extended from the limbus towards the visual axis. Five patients were observed for a minimum of 18 months after stopping contact lens wear before undergoing limbal transplantation. A good result was obtained in 1 patient who had worn a contact lens in one eye only. Recurrent epithelial changes were observed on the recipient eyes of the remaining patients who had previously worn contact lenses bilaterally, and in 1 patient epithelial haze also developed adjacent to the donor site in the previously clinically normal donor eye. All 5 patients experienced an improvement in symptoms post-operatively but in 2 patients the visual acuity later deteriorated because of epithelial irregularity. The sixth patient has not had surgery. We conclude that limbal stem cell dysfunction in chronic contact-lens-associated epitheliopathy may be subclinical and that autograft transplantation in bilaterally exposed patients may fail to restore the epithelial phenotype of the host eye whilst jeopardising the epithelial integrity of the donor eye by depleting its stem cell reserve.

Entities:  

Mesh:

Year:  1993        PMID: 8287983     DOI: 10.1038/eye.1993.145

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  36 in total

1.  Amniotic membrane transplantation for partial limbal stem cell deficiency.

Authors:  D F Anderson; P Ellies; R T Pires; S C Tseng
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

Review 2.  Outcomes of Limbal Stem Cell Transplant: A Meta-analysis.

Authors:  Qihua Le; Tulika Chauhan; Madeline Yung; Chi-Hong Tseng; Sophie X Deng
Journal:  JAMA Ophthalmol       Date:  2020-06-01       Impact factor: 7.389

3.  Cultured corneal epithelia for ocular surface disease.

Authors:  I R Schwab
Journal:  Trans Am Ophthalmol Soc       Date:  1999

4.  Limbal stem cell disease: Treatment and advances in technology.

Authors:  Hall F Chew
Journal:  Saudi J Ophthalmol       Date:  2011-05-24

5.  Assessment of limbus and central cornea in patients with keratolimbal allograft transplantation using in vivo laser scanning confocal microscopy: an observational study.

Authors:  Jiaxu Hong; Tianyu Zheng; Jianjiang Xu; Sophie X Deng; Ling Chen; Xinghuai Sun; Qihua Le; Yimin Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-26       Impact factor: 3.117

6.  Autologous limbal transplantation in patients with unilateral corneal stem cell deficiency.

Authors:  H S Dua; A Azuara-Blanco
Journal:  Br J Ophthalmol       Date:  2000-03       Impact factor: 4.638

7.  Two separate methods of stem cell transplantation in both eyes of a single patient presented with bilateral stem cell deficiency following exposure to Euphorbia latex.

Authors:  Jayanta Dutta; Somnath Mukhopadhyay; Kapil D Lahiri; Himadri Datta
Journal:  J Ocul Biol Dis Infor       Date:  2013-06-12

Review 8.  Contact Lens-induced Limbal Stem Cell Deficiency.

Authors:  Jennifer Rossen; Alec Amram; Behrad Milani; Dongwook Park; Jennifer Harthan; Charlotte Joslin; Timothy McMahon; Ali Djalilian
Journal:  Ocul Surf       Date:  2016-07-30       Impact factor: 5.033

9.  ROCK inhibitor Y-27632 increases the cloning efficiency of limbal stem/progenitor cells by improving their adherence and ROS-scavenging capacity.

Authors:  Qingjun Zhou; Haoyun Duan; Yao Wang; Mingli Qu; Lingling Yang; Lixin Xie
Journal:  Tissue Eng Part C Methods       Date:  2012-12-28       Impact factor: 3.056

10.  Minimal conjunctival limbal autograft for total limbal stem cell deficiency.

Authors:  Ahmad Kheirkhah; Vadrevu K Raju; Scheffer C G Tseng
Journal:  Cornea       Date:  2008-07       Impact factor: 2.651

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.